Ingenious Targeting Laboratory
Private Company
Total funding raised: $5M
Overview
Ingenious Targeting Laboratory is a long-established, specialized service provider in the preclinical animal model space, leveraging over 25 years of experience in genetic engineering. The company operates as a contract research organization (CRO), offering custom model generation (knockout, knockin, humanized, transgenic), access to a catalog of over 10,000 models, and integrated preclinical phenotyping services. Its value proposition centers on rigorous U.S.-based quality control, expertise in complex allele design for long-term stability, and the provision of study-ready cohorts on reproducible genetic backgrounds. With a track record of 2,500+ projects and 800+ publications, ITL serves as a critical partner for researchers requiring high-fidelity animal models for target validation and translational research.
Technology Platform
Technology-agnostic integrated platform for custom genetically engineered mouse model (GEMM) creation. Utilizes appropriate genome-editing technologies (e.g., CRISPR) followed by a systematic workflow encompassing allele design, construct synthesis, embryo injection, germline transmission, and colony expansion on controlled C57BL/6 backgrounds. Emphasis on structured allele design for long-term stability and reproducibility.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ITL competes with other specialized animal model CROs (e.g., Taconic Biosciences, Cyagen, The Jackson Laboratory's Custom Model Services) and academic core facilities. Its differentiation is based on 25+ years of experience, a focus on complex allele design for stability, rigorous U.S.-based QC, and the provision of study-ready cohorts on pure C57BL/6 backgrounds. Competition is intensifying as gene-editing tools become more accessible.